23andMe
-
Study On Side Effects of Parkinson’s Medication
Aug 11
23andMe posted information on a new genetic study that may help those looking for ways to avert some of the troubling side effects of a common medication used to treat Parkinson’s disease. Parkinson’s is sometimes treated with medication that increases dopamine activity in the brain. In some patients, that triggers impulsivity, such as ...
-
New 23andMe Report on Rosacea
Jul 13
23andMe released a new report Powered by 23andMe Research on Rosacea for 23andMe+ members. Rosacea is a chronic skin condition that typically affects the central parts of the face. It is commonly characterized by flushing, redness, and visible blood vessels, but symptoms can vary; some individuals experience irritation or inflammation of th...
-
23andMe Updated Report for People with Asian Ancestry
Jun 21
23andMe updated its report on an inherited condition characterized by mild to profound hearing loss. The update to 23andMe’s Nonsyndomic Hearing Loss and Deafness, DFNB1 (GJB1-Related) Carrier Status Report adds six variants that improve the coverage of the test for people with East Asian, Southeast Asian, and South Asian ancestry. “We ...
-
23andMe Has A Study About Long COVID
Jun 1
In what is among the largest studies of long COVID to date, researchers at 23andMe confirm that it disproportionately impacts women, and being diagnosed with depression or anxiety is associated with more than a two-fold increase in risk for the condition. The study also found that about half of those with persistent symptoms are experiencing ...
-
23andMe Acquired Lemonaid Health
May 10
23andMe announced another step toward unlocking the power of genetic health information. 23andMe acquired Lemonaid Health, a telemedicine company, last fall. Instead of being treated for an illness, most of us would prefer to avoid getting sick in the first place. But in large measure, our health care system isn’t geared for that. It’...
-
23andMe New Study on Depression and Bipolar Disorder
Apr 12
A 23andMe study published in April of 2022 provides insight into the cause and overlapping genetics of two mental health disorders - depression and bipolar disorder. The National institutes of Health estimates that more than 16 million Americans are affected by depression each year, while nearly 6 million Americans have bipolar disorder. Ge...
-
California Expands Consumer Protections for Genetic Testing
Oct 21
23andMe knows you care about privacy, and they have been working hard to deliver other promises of transparency and choice, even beyond your experience at 23andMe. 23andMe is excited to share that California recently enacted a new law to protect consumers’ genetic data privacy. 23andMe has worked hard with the Coalition for Genetic Data P...
-
23andMe Provides Equity and Inclusion for People with Disabilities
Oct 14
23andMe’s CEO and Co-Founder, Anne Wojcicki, signed a letter, along with dozens of CEOs, making a commitment toward advancing equity and inclusion for employees and customers with disabilities. The move deepened 23andMe’s ongoing commitment to diversity, equity, and inclusion through participating in the Diversity Equality Index. The in...
-
23andMe is More Inclusive for All Genders
Sep 9
23andMe announced some important updates to give customers greater control over tailoring their product experience so it more accurately reflects their gender. 23andMe now allows customers to distinguish between their sex assigned at birth and their gender. This allows all customers, but especially their transgender and/or non-binary custom...
-
23andMe Adds 8 New Regions of Indigenous Genetic Ancestry
Aug 19
23andMe added eight new regions in North America reflecting Indigenous genetic ancestry. The addition is in response to not just requests from thousands of customers, but also as part of an ongoing effort to create a 23andMe Ancestry Service that better reflects the diverse genetic ancestries of their customers. With guidance from experts i...